4
Changes in Ownership
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001127602-23-028591
EVP, Corp Strategy & Develop sold 1,850 shares at $197.73 ($365,801)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LaPlume Joseph W EVP, Corp Strategy & Develop | 2023-11-30 | Sale | −1,850 | $197.73 | $365,801 | 23,133 | D |
| Open-market sales · 1,850 sh · avg $197.73 · $365,801 | |||||||
Loading xslF345X05/form4.xml…